CORE LITHIUM LTD — Director's Dealing 2020

Jul 23, 2020

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity	Core Lithium Ltd
ABN	80 146 287 809

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	StephenBIGGINS
Date of last notice	23 April 2020

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Indirect
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	1. Mr Biggins is a director of and has a beneficial interest in the registered holder Nowak Investments Pty Ltd ATF The Nowak Superannuation Fund (Nowak) 2. Mr Biggins is a director of and has a beneficial interest in the registered holder Genex Resources Pty Ltd ATF Biggins Resources Family Trust (Genex)
Date of change	23 July 2020

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

No. of securities held prior to change	5,979,680 Shares held by Nowak 2,216,667 Shares held by Genex 14,000,000 unlisted Performance Rights subject to vesting criteria, expiring at various times to 30 June 2026 held by Genex 5,000,000 Options held by Genex
Class	Shares - Fully paid ordinary shares. Performance Rights – unquoted performance rights subject to satisfaction of performance conditions. Options - unquoted options with an exercise price of 6.0 cents each and expiry of 30 June 2023.
Number acquired	Nil
Number disposed	2,083,334 Performance Rights
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	Nil
No. of securities held after change	5,979,680 Shares held by Nowak 2,216,667 Shares held by Genex 9,750,000 Performance Rights expiring at various times to 30 June 2026 held by Genex. 2,166,666 vested Performance Rights expiring at 30 June 2023 held by Genex. 5,000,000 Options held by Genex
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back	Lapse of director performance rights as vesting condition was not met and vesting of rights.

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	Not applicable
Nature of interest
Name of registered holder (if issued securities)
Date of change
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed
Interest acquired
Interest disposed
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation
Interest after change

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailed above traded during a+closed period where prior written clearance was required?	Not applicable
If so, was prior written clearance provided to allow the trade to proceed during this period?
If prior written clearance was provided, on what date was this provided?

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3